Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 118K 107K 200K 13.61M 204K 1.41M 565K 7.16M 538K 527K 22.58M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.55M 18.91M 17.13M 32.02M 2.18B 32.62M 225M 90.5M 1.15B 86.12M 84.29M 3.61B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.72% | +3.44% | +22.84% | +56.71% | 258B | ||
| -2.00% | +0.75% | +7.82% | +20.94% | 163B | ||
| -3.73% | -4.48% | -19.14% | +64.75% | 150B | ||
| -1.66% | -8.12% | -58.32% | -17.99% | 60.84B | ||
| -.--% | +2.46% | -11.69% | -7.41% | 53.31B | ||
| -2.57% | +3.30% | +11.59% | +44.40% | 53.03B | ||
| +0.84% | -3.12% | +7.47% | +62.40% | 50.67B | ||
| -3.47% | +1.04% | +19.48% | +69.17% | 49.3B | ||
| -3.61% | +1.99% | +32.36% | +93.99% | 45.46B | ||
| Average | -1.99% | -0.30% | +1.38% | +43.00% | 98.16B | |
| Weighted average by Cap. | -2.10% | +0.15% | +4.02% | +44.65% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.55M 1.42M 1.29M 2.41M 164M 2.46M 16.99M 6.82M 86.38M 6.49M 6.35M 272M | 1.98M 1.77M 1.63M 1.48M 2.76M 188M 2.81M 19.43M 7.8M 98.78M 7.42M 7.26M 312M |
| Net income | -16.08M -14.4M -13.24M -12M -22.43M -1.53B -22.85M -158M -63.4M -803M -60.33M -59.05M -2.53B | -29.31M -26.25M -24.15M -21.88M -40.9M -2.78B -41.67M -288M -116M -1.46B -110M -108M -4.62B |
| Net Debt | 20.53M 18.38M 16.91M 15.32M 28.64M 1.95B 29.18M 202M 80.95M 1.03B 77.03M 75.39M 3.23B | 22.8M 20.42M 18.79M 17.02M 31.82M 2.17B 32.41M 224M 89.94M 1.14B 85.58M 83.76M 3.59B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















